(Q46887438)

26 December 2017

title

Significant correlations between severe fatty liver and risk factors for metabolic syndrome (English)

1 reference

26 December 2017

1 reference

Pi-Jung Hsiao

1

1 reference

26 December 2017

Kung-Kai Kuo

2

1 reference

26 December 2017

Shyi-Jang Shin

3

1 reference

26 December 2017

Yi-Hsin Yang

4

1 reference

26 December 2017

Wen-Yi Lin

5

1 reference

26 December 2017

Jeng-Fu Yang

6

1 reference

26 December 2017

Chao-Chin Chiu

7

1 reference

26 December 2017

Wan-Long Chuang

8

1 reference

26 December 2017

Tong-Rong Tsai

9

1 reference

26 December 2017

Ming-Lung Yu

10

1 reference

26 December 2017

publication date

1 December 2007

1 reference

26 December 2017

Journal of Gastroenterology and Hepatology

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 December 2017

volume

22

1 reference

26 December 2017

page(s)

2118-2123

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Non-alcoholic fatty liver disease: an emerging pathological spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Report of the expert committee on the diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Non-alcoholic steatohepatitis: review of a growing medical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Obesity: an overview on its current perspectives and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04698.X

10.1111/J.1440-1746.2006.04698.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

release_iv55quf5vrfiddjytff4gf3shu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iv55quf5vrfiddjytff4gf3shu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18031368

1 reference

26 December 2017